{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:02Z","timestamp":1792000982991,"version":"4.4.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.neuropharm.2023.109706","type":"journal-article","created":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:44:59Z","timestamp":1693716299000},"page":"109706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Hydralazine inhibits neuroinflammation and oxidative stress in APP\/PS1 mice via TLR4\/NF-\u03baB and Nrf2 pathways"],"prefix":"10.1016","volume":"240","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8839-4085","authenticated-orcid":false,"given":"Jiayang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5184-6899","authenticated-orcid":false,"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6395-9732","authenticated-orcid":false,"given":"Xiaoming","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-5316","authenticated-orcid":false,"given":"Tianyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-7698","authenticated-orcid":false,"given":"Rui","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2822-7576","authenticated-orcid":false,"given":"Geming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3021-8863","authenticated-orcid":false,"given":"Yunxiao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109706_bib1","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1021\/acschemneuro.9b00329","article-title":"Gracilin A derivatives target early events in alzheimer's disease: in vitro effects on neuroinflammation and oxidative stress","volume":"10","author":"Alvari\u00f1o","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2020.183531","article-title":"Amyloid \u03b2, \u03b1-synuclein and the c subunit of the ATP synthase: can these peptides reveal an amyloidogenic pathway of the permeability transition pore?","volume":"1863","author":"Amodeo","year":"2021","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.neuropharm.2023.109706_bib3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neuroscience.2005.08.029","article-title":"Sex-differences in age-related cognitive decline in C57BL\/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity","volume":"137","author":"Benice","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2023.109706_bib4","article-title":"Morris water maze test for learning and memory deficits in Alzheimer's disease model mice","volume":"53","author":"Bromley-Brits","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2023.109706_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/986075","article-title":"Elevation of HO-1 expression mitigates intestinal ischemia-reperfusion injury and restores tight junction function in a rat liver transplantation model","volume":"2015","author":"Chi","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2023.109706_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144345","article-title":"Comparison of gene expression by sheep and human blood stimulated with the TLR4 agonists lipopolysaccharide and monophosphoryl lipid A","volume":"10","author":"Enkhbaatar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109706_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbr.2009.12.036","article-title":"One-trial object recognition in rats and mice: methodological and theoretical issues","volume":"215","author":"Ennaceur","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109706_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2014.07.050","article-title":"Interactions of innate and adaptive immunity in brain development and function","volume":"1617","author":"Filiano","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109706_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pneurobio.2006.07.001","article-title":"Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration","volume":"79","author":"Foster","year":"2006","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in alzheimer's disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonz\u00e1lez-Reyes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fneur.2019.00271","article-title":"Hydralazine protects nigrostriatal dopaminergic neurons from MPP(+) and MPTP induced neurotoxicity: roles of nrf2-ARE signaling pathway","volume":"10","author":"Guo","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib12","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2023.109706_bib13","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1146\/annurev.bi.54.070185.005055","article-title":"The mitochondrial electron transport and oxidative phosphorylation system","volume":"54","author":"Hatefi","year":"1985","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2023.109706_bib14","series-title":"Differential Effect of Angiotensin II and Blood Pressure on Hippocampal Inflammation in Mice","author":"Iulita","year":"2018"},{"key":"10.1016\/j.neuropharm.2023.109706_bib15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.neuropharm.2023.109706_bib16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7150\/ijbs.26703","article-title":"Changes in chemokines and chemokine receptors expression in a mouse model of alzheimer's disease","volume":"15","author":"Jorda","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109706_bib18","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.12.041","article-title":"Arylbenzofuran isolated from Dalbergia odorifera suppresses lipopolysaccharide-induced mouse BV2 microglial cell activation, which protects mouse hippocampal HT22 cells death from neuroinflammation-mediated toxicity","volume":"728","author":"Lee","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib20","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/nprot.2013.155","article-title":"Object recognition test in mice","volume":"8","author":"Leger","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2023.109706_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.eururo.2014.10.013","article-title":"Novel therapeutic approach for neurogenic erectile dysfunction: effect of neurotrophic tyrosine kinase receptor type 1 monoclonal antibody","volume":"67","author":"Lin","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108342","article-title":"Sigma ligands as potent inhibitors of A\u03b2 and A\u03b2Os in neurons and promising therapeutic agents of Alzheimer's disease","volume":"190","author":"Ma","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109706_bib23","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1002\/jcb.30141","article-title":"Distinct types of amyloid-\u03b2 oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease","volume":"122","author":"Madhu","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.neuropharm.2023.109706_bib24","doi-asserted-by":"crossref","first-page":"10371","DOI":"10.1021\/bi101249p","article-title":"Hydralazine modifies A\u03b2 fibril formation and prevents modification by lipids in vitro","volume":"49","author":"Maheshwari","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2023.109706_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pnpbp.2010.07.004","article-title":"Mitochondrial dysfunction and Alzheimer's disease","volume":"35","author":"Maruszak","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109706_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0006-2952(03)00083-2","article-title":"Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation","volume":"65","author":"Myhre","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib28","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/jnen\/59.11.1011","article-title":"Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome","volume":"59","author":"Nunomura","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease","volume":"72","author":"Ozben","year":"2019","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.neuropharm.2023.109706_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14728222.2016.1121237","article-title":"Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation","volume":"20","author":"Pe\u00f1a-Altamira","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.neuropharm.2023.109706_bib31","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1038\/s41380-022-01565-z","article-title":"The synapse as a treatment avenue for Alzheimer's Disease","volume":"27","author":"Peng","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109706_bib32","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1523\/JNEUROSCI.1136-17.2017","article-title":"Microglia-mediated synapse loss in alzheimer's disease","volume":"38","author":"Rajendran","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib33","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1021\/bi00232a015","article-title":"J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential","volume":"30","author":"Reers","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2023.109706_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111828","article-title":"The role of mitochondrial dysfunction in Alzheimer's disease: a potential pathway to treatment","volume":"164","author":"Reiss","year":"2022","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3644318","article-title":"Nrf2 deficiency attenuates testosterone efficiency in ameliorating mitochondrial function of the substantia nigra in aged male mice","volume":"2022","author":"Ren","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2023.109706_bib36","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.3390\/molecules25225474","article-title":"An overview of Nrf2 signaling pathway and its role in inflammation","volume":"25","author":"Saha","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2023.109706_bib37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109706_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2023.109706_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094850","article-title":"Mitochondrial dysfunction as a driver of cognitive impairment in alzheimer's disease","volume":"22","author":"Sharma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jns.2016.05.022","article-title":"Upstream regulators and downstream effectors of NF-\u03baB in Alzheimer's disease","volume":"366","author":"Shi","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib41","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2022.09.025","article-title":"Redox stress and metal dys-homeostasis appear as hallmarks of early prion disease pathogenesis in mice","volume":"192","author":"Spiers","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2023.109706_bib42","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3233\/JAD-170585","article-title":"Mitochondria and mitochondrial cascades in alzheimer's disease","volume":"62","author":"Swerdlow","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuropharm.2023.109706_bib43","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00204-015-1556-z","article-title":"Oxidative stress in Alzheimer disease and mild cognitive impairment: evidence from human data provided by redox proteomics","volume":"89","author":"Swomley","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2023.109706_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib45","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","article-title":"Protective effects of NSAIDs on the development of Alzheimer disease","volume":"70","author":"Vlad","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2023.109706_bib46","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","article-title":"Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease","volume":"117","author":"Wang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2023.109706_bib47","article-title":"Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's disease","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2023.109706_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.772717","article-title":"Microglia polarization in alzheimer's disease: mechanisms and a potential therapeutic target","volume":"13","author":"Wang","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109706_bib49","article-title":"Pentoxifylline enhances antioxidative capability and promotes mitochondrial biogenesis in D-galactose-induced aging mice by increasing Nrf2 and PGC-1 through the cAMP-CREB pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2023.109706_bib50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/BST20150014","article-title":"Dissecting molecular cross-talk between Nrf2 and NF-\u03baB response pathways","volume":"43","author":"Wardyn","year":"2015","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2023.109706_bib51","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4103\/1673-5374.355747","article-title":"The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease","volume":"18","author":"Wu","year":"2023","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.neuropharm.2023.109706_bib52","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/09637486.2016.1198890","article-title":"Ferulic acid ameliorates memory impairment in d-galactose-induced aging mouse model","volume":"67","author":"Yang","year":"2016","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.neuropharm.2023.109706_bib53","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/biomedicines9111587","article-title":"Mitochondrial electron transport chain protein abnormalities detected in plasma extracellular vesicles in alzheimer's disease","volume":"9","author":"Yao","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.neuropharm.2023.109706_bib54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnagi.2018.00042","article-title":"Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in alzheimer's disease brain: a review","volume":"10","author":"Zhan","year":"2018","journal-title":"Front. Aging Neurosci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:25:43Z","timestamp":1758439543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823002964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"alternative-id":["S0028390823002964"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109706","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydralazine inhibits neuroinflammation and oxidative stress in APP\/PS1 mice via TLR4\/NF-\u03baB and Nrf2 pathways","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109706"}}